Quick Answer
A founder building her senior team faces three very different people across the table in the same month. A CTO candidate who wants real ownership and will wait years for it. A superstar advisor who adds enormous value but will never be an employee. And a veteran operations head who says, plainly, “I have seen paper equity before; I want something that pays cash when the company wins.” One instrument cannot serve all three, and Indian law does not ask it to. The toolkit contains at least three distinct devices, employee stock options, phantom stock, and sweat equity shares, plus a couple of cousins worth knowing. Choosing well is a matching exercise: person, purpose, cash reality, and tax. This article lays the instruments side by side so the matching becomes obvious.
- These three instruments answer three different questions. Who is building the future with you full time: options. Who shares your upside but cannot or should not hold shares: phantom. Whose already delivered work is the company standing on: sweat equity. Match the instrument to the person’s role, cash needs, and tax reality, respect each instrument’s separate legal machinery, and resist the urge to force one tool onto every hire, because compensation design, like carpentry, goes wrong exactly when the only tool you respect is a hammer.

ESOPs: the default, and deservedly so
An employee stock option is a right, not an obligation, to buy shares in the future at a price fixed today, contingent on staying and vesting. For private companies the framework is Section 62(1)(b) of the Companies Act, 2013 and Rule 12 of the Share Capital and Debentures Rules: shareholder approved scheme, minimum one year vesting, SH-6 register, the machinery we cover in our pillar guide to structuring an ESOP scheme. The economics: the employee pays the exercise price when exercising, and tax arrives in two instalments, perquisite tax at exercise on the gap between fair market value and exercise price, then capital gains at sale on growth beyond that. No shares exist until exercise, so there is no dilution and no shareholder rights, no voting, no dividends, until then. ESOPs fit the long game: employees you want locked into a multi year value creation story, at a stage where cash salaries cannot compete with larger companies. They fit poorly where the person is not an employee, since Rule 12 restricts grants to employees and directors within limits, promoters generally excluded outside the startup relaxation window, or where the person needs cash outcomes rather than paper.
Phantom stock: the economics without the equity
Phantom stock, and its sibling the stock appreciation right or SAR, is a contract, not a security. The company promises to pay cash equal to the value, or the appreciation in value, of a notional number of shares when a defined event occurs, vesting completion, an exit, a valuation milestone. No shares are issued. Ever. The cap table never hears about it. That single fact drives every consequence. Because nothing is issued, there is no Section 62 process, no shareholder resolution, no dilution, no minority shareholder accumulating rights. Design freedom is nearly total: any vesting curve, any trigger, any participant, including consultants, advisors, and even promoters, whom ESOP rules exclude. Confidentiality is easy, since one executive’s phantom plan need not be visible to anyone else. The costs are the mirror image. Payouts are cash, so the plan is a future liability on the company’s own P&L, and a phantom plan that pays out at exit reduces the very pot it is measured against, model this, acquirers certainly will. For the recipient, the payout is salary like income taxed at slab rates, with no capital gains treatment, because they never owned an asset. And psychologically, phantom equity is felt as a bonus scheme, not ownership; it rents motivation rather than buying loyalty. Phantom stock fits the operations head who wants cash on success, the consultant CFO, the advisor network, and family business scenarios where the family will not dilute but wants professionals to share the upside.
Sweat equity: real shares, issued now, for value already given
Sweat equity shares are actual equity, issued today, at a discount or for consideration other than cash, in recognition of know how, intellectual property, or value additions already delivered. The governing law is Section 54 of the Companies Act, 2013 and the related rules: special resolution, issuance limits per year and in aggregate, a lock in period of three years, and valuation by a registered valuer. Read that description against the other two instruments and the differences leap out. Sweat equity is retrospective, it rewards contribution already made, where options are prospective bets on future service. It is immediate ownership: voting, dividends, a line on the cap table, locked in for three years. And it is taxed on receipt, the fair value of the shares less anything paid is a perquisite in the year of allotment, cash tax on paper shares, so plan the money. Sweat equity fits a narrow but important cast: the technical co-founder who contributed the core IP before incorporation formalities caught up, the scientist whose patent the company is built on, the director whose know how is the product. It is a scalpel, not a shovel; issuing sweat equity broadly to rank and file employees is almost always the wrong tool.
The comparison in one paragraph
Options give future ownership for future service, tax deferred until exercise and sale, dilute later, and require the full Companies Act scheme machinery. Phantom gives cash economics with no ownership and no dilution, taxed as salary on payout, governed only by contract, and sits as a liability on your books. Sweat equity gives real shares now for value already delivered, taxed now, diluting now, locked for three years, under Section 54’s limits and valuation discipline. Or in founder shorthand: options for the team you are building, phantom for the allies you cannot or will not dilute for, sweat equity for the person whose past work is the company. Return to our three hires. The CTO gets ESOPs, four year vesting, meaningful percentage, because ownership is what he is buying with his salary discount. The advisor gets phantom units payable on exit, because Rule 12 would not let options reach her anyway and she values a clean cash contract. The operations veteran gets a SAR plan with staged cash triggers, because he told you plainly what motivates him, and the instrument that matches stated motivation always outperforms the instrument that flatters the founder’s imagination.
Can AI help choose and manage these instruments?
As an analyst, yes. AI tools can model the ten year cost of each instrument side by side, dilution under ESOPs versus cash liability under phantom versus immediate dilution plus lock in under sweat equity, compute the recipient’s after tax outcome under each, and draft first versions of scheme documents, SAR contracts, and board resolutions. That comparative modelling, which advisers once built over a week, now takes an afternoon, and it makes the trade-offs vivid before you commit. What AI cannot responsibly do is make the classification calls: whether a promoter can lawfully receive a given instrument, whether your startup qualifies for Rule 12 relaxations, how a phantom liability should sit in your accounts, or how SEBI’s rules change everything if listing enters the plan. Those carry statutory consequences, and a qualified human should own them, using the machine’s models as evidence rather than verdicts.
When to Review This
- These three instruments answer three different questions. Who is building the future with you full time: options. Who shares your upside but cannot or should not hold shares: phantom. Whose already delivered work is the company standing on: sweat equity. Match the instrument to the person’s role, cash needs, and tax reality, respect each instrument’s separate legal machinery, and resist the urge to force one tool onto every hire, because compensation design, like carpentry, goes wrong exactly when the only tool you respect is a hammer.
Disclaimer
This article is for general information only and is not legal advice. Instrument choice depends on your specific facts, so take professional advice before acting.

